Effective clinical trials investigators and adequate incentives

Jeremiah Stamler*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Because of the importance of randomized controlled trials in medical research and development, the most competent and qualified individuals from a variety of medical specialties are needed as investigators for these trials. Such people must be highly dedicated to the improvement of human health and they must also be cooperative and able to work in the highly disciplined atmosphere that such a trial demands. In order that the trial investigators be persons of high caliber, certain incentives must be guaranteed, such as recognition of one's contributions to the trial itself, publications, and opportunities to present study results at various meetings. University and medical school policies on promotion and tenure need to be reassessed bearing in mind the complexity of achieving optimal recognition of the individual investigator's contributions to a clinical trial.

Original languageEnglish (US)
Pages (from-to)666-670
Number of pages5
JournalClinical pharmacology and therapeutics
Volume25
Issue number5 PART 2
DOIs
StatePublished - May 1979

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Fingerprint

Dive into the research topics of 'Effective clinical trials investigators and adequate incentives'. Together they form a unique fingerprint.

Cite this